Abstract
Background The COVID-19 pandemic accelerated the adoption of telehealth in healthcare delivery and education. However, the integration of telehealth into medical curricula is often limited to institutional initiatives and remains scattered. This raises questions about the experienced barriers and enablers for education in telehealth consultation.
Objective This study sought to explore medical students’ and educators’ experiences with telehealth consultations in academic and clinical learning environments during the pandemic in the United Kingdom.
Methods A cross-sectional mixed-methods design was employed. Quantitative data was gathered via online questionnaires, while qualitative insights were derived from semi-structured interviews. A total of 248 participants (153 students, 87 educators) responded to the survey, of those, 23 participants (13 students, 10 educators) were interviewed.
Results Telehealth consultations were primarily taught and delivered during clinical placements. The pandemic and subsequent educational adjustments were identified as enabling factors. Exposure to telehealth increased students’ confidence and readiness, particularly through active participation in consultations. Barriers included inadequate technical infrastructure, lack of confidential spaces, and limited confidence of educators teaching telehealth consultation.
Conclusion The findings highlight the need for an integrated telehealth curriculum that incorporates practical exposure and addresses technical limitations in both universities as well as healthcare settings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Initial ethics approval was received from the School of Medicine at the University of St Andrews (approval code MD15263). Two ethical amendments were approved to reflect changes to the initial recruitment strategy. Additional approval and permission to undertake the research was provided by the UK Medical Schools Council (MSC), and individual UK medical schools upon request.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Email: lisa.kephart{at}glenville.edu, aso2{at}st-andrews.ac.uk
Data Availability
Data are available from the University of St Andrews Research Repositry under: https://doi.org/10.17630/84eb74f3-e316-4618-a112-19b2f24377ac The data set will be made availableon 9 May 2028.
https://doi.org/10.17630/84eb74f3-e316-4618-a112-19b2f24377ac
